Benzinga
Benzinga
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Benzinga
martes, noviembre 17
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Kestra Medical Technologies Ltd
KMTS
NASDAQ
Lista de seguimiento
Get Report
Trade with Public
Get Report
Trade with Public
$28.27
0.30
1.07%
al cierre: Nov 17, 4:00 PM EST
$28.27
N/A
After hour: 4:00 PM EST
Get Report
Panorámica general
Noticias
Gráficos
Previsión de beneficios
Eventos
Precios objetivo
Finanzas
Sentimiento
Propiedad
Comparar
Informe de acciones
Kestra Medical Techs Financials
Kestra Medical Techs (KMTS) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
Kestra Medical Techs Q1 EPS $(0.75) Misses $(0.62) Estimate, Sales $30.971M Beat $29.007M Estimate
Kestra Medical Techs (NASDAQ:KMTS) reported quarterly losses of $(0.75) per share which missed the analyst consensus estimate of $(0.62) by 20.97 percent. This is a 50 percent decrease over losses of $(0.50) per share
Benzinga Newsdesk
PRO
Kestra Medical Techs Raises FY2027 Sales Guidance from $137.000M to $141.000M vs $137.023M Est
Kestra Medical Techs (NASDAQ:KMTS) raises FY2027 sales outlook from $137.000 million to $141.000 million vs $137.023 million estimate.
Benzinga Newsdesk
Kestra Likely To Report Q1 Loss; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Kestra Medical Technologies will report its first earnings Sept. 14, with analysts expecting a $0.62 EPS loss and $29.01M revenue.
Avi Kapoor
PRO
Kestra Medical Techs Sees FY2027 Sales $137.000M vs $132.895M Est
Kestra Medical Techs (NASDAQ:KMTS) sees FY2027 sales of $137.000 million vs $132.895 million analyst estimate.
Benzinga Newsdesk
PRO
Kestra Medical Techs Q4 EPS $(0.67) Misses $(0.59) Estimate, Sales $28.638M Beat $26.479M Estimate
Kestra Medical Techs (NASDAQ:KMTS) reported quarterly losses of $(0.67) per share which missed the analyst consensus estimate of $(0.59) by 13.56 percent. This is a 69.68 percent increase over losses of $(2.21) per
Benzinga Newsdesk
Earnings Scheduled For July 14, 2026
Companies Reporting Before The Bell • Grupo Aeroportuario del (NYSE:PAC) is likely to report quarterly earnings at $3.25 per share on revenue of $862.92 million. • JPMorgan Chase (NYSE:JPM) is projected to report
Benzinga Insights